©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111727
Table 3 Performance of the GALAD score using healthy individuals or patients with cirrhosis as reference
| Response variable | AUC | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) |
| Control (Ref.) | ||||||
| HCC | 0.9725; (K-fold = 0.9743); Δ = 0.0018 | 85.23 | 98.86 | 94.94 | 96.40 | 96.14 |
| Cirrhosis (Ref.) | ||||||
| HCC | 0.8609; (K-fold = 0.8657); Δ = 0.0048 | 47.73 | 95.28 | 76.36 | 85.09 | 83.77 |
- Citation: Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G. Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. World J Gastroenterol 2025; 31(40): 111727
- URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111727